Arkema's Stock Surges 2.67% Amid Middle East De-escalation

Arkema's Shares Regain Ground

Arkema's stock is recovering this Wednesday, after a 0.8% decline over the past seven days. The stock is benefiting from a more favorable market environment, with the CAC 40 up 1.38% in the session at 7,851 points. This Parisian market improvement follows the de-escalation announced on March 23 between Washington and Tehran regarding the Strait of Hormuz, which led to a sharp rebound in European indices after a morning of high tensions. Technically, the price is currently just below its 50-day moving average (55.81 euros) and its 200-day moving average (56.32 euros). Crossing these thresholds would signal an improvement in the medium-term dynamics. The RSI, at 48, indicates a neutral configuration, without excessive buying or selling, leaving the stock in a waiting zone. The most relevant support is at 50.50 euros, a level tested during recent pullback sessions.

Arkema's Yearly Underperformance Despite Recent Gains

Despite the progress recorded in recent weeks — the stock has gained 9.31% over three months — Arkema still shows a decline of 26.26% over one year. This prolonged underperformance reflects the challenges faced by the specialty chemicals sector, dealing with a more uncertain demand environment and margin pressures. The next major events for shareholders are scheduled for May 6, 2026, with the publication of the first-quarter results, followed by the general meeting on May 21. These dates will be crucial to assess the operational trajectory of the group and its ability to consolidate the rebound that began earlier this year. In the same industrial sector, other companies also show session gains: Schneider Electric is up 2.73% and Airbus advances by 1.71%, confirming the positive mood dominating the Paris market this Wednesday.